Dove e quando
2018-12-20 | DIBRIS, University of Genoa, Aula Tagliasco (Villa Bonino), Viale Francesco Causa 13, Genova
For the last couple of decades, researchers from around the world have invested time and effort to bring nanoscience and nanotechnology to medicine. The National Cancer Institute (NCI) has been at the forefront in supporting these efforts with their highly successful Alliance for Nanotechnology in Cancer Program. Building on progress in the molecular sciences and advanced technologies, new perspectives may emerge through the exploration of trending engineering principles that could help shape and further accelerate the emergence of nanomedicine into healthcare. In this talk, examples of blending novel physical sciences/engineering perspectives with medicine will be presented to illustrate that fostering the development of such innovating and promising approaches in nanomedicine could lead to a paradigm shift in the way we understand and ultimately implement it into treating various types of diseases. Dr. Larry Nagahara is currently the Associate Dean for Research in the Whiting School of Engineering and Research Professor in the Department of Chemical and Biomolecular Engineering at Johns Hopkins University. Previously, he was the Associate Director within the Division of Cancer Biology at National Cancer Institute (NCI)/National Institutes of Health (NIH), where he directed and coordinated programs and research activities related to expanding the role of the physical sciences and engineering in cancer research. Before joining NCI, Dr. Nagahara was a Distinguished Member of the Technical Staff at Motorola and led their nanosensor effort. He is a Fellow of the American Association for the Advancement of Science (AAAS), American Institute for Medical and Biological Engineering (AIMBE), American Physical Society (APS), IEEE, and a former member of Motorola's Scientific Advisory Board.
Larry A. Nagahara